Which medications are contraindicated with loop diuretics such as furosemide, bumetanide, torsemide, and ethacrynic acid?

Medications Contraindicated with Loop Diuretics

Avoid NSAIDs (non-steroidal anti-inflammatory drugs) when using loop diuretics, as they significantly reduce diuretic efficacy and increase the risk of acute renal failure. 1, 2

Absolute Contraindications

Aminoglycoside Antibiotics

• Avoid concomitant use with loop diuretics if possible due to synergistic ototoxicity 2
• Specifically documented with gentamycin and torsemide 2
• Ethacrynic acid carries the highest ototoxic risk among loop diuretics and should particularly be avoided with aminoglycosides 3

Ethacrynic Acid (when using other loop diuretics)

• Loop diuretics increase the ototoxic potential of ethacrynic acid 2
• Do not combine ethacrynic acid with other ototoxic drugs 3

Relative Contraindications & High-Risk Combinations

NSAIDs and Salicylates

• NSAIDs reduce antihypertensive and diuretic effects of loop diuretics 2
• High-dose salicylates compete for renal tubular secretion, causing salicylate toxicity 2
• Concomitant use associated with acute renal failure development 2
• Indomethacin specifically inhibits natriuretic effect under sodium restriction 2

Potassium-Sparing Diuretics (During Initiation)

• Avoid during ACE inhibitor initiation in heart failure patients 1
• The combination of potassium-sparing diuretics with ACE inhibitors was historically considered dangerous 1
• Use only if hypokalaemia persists after ACE inhibitor and diuretic therapy established 1
• Requires monitoring serum potassium and creatinine every 5-7 days until stable 1

Lithium

• Loop diuretics reduce renal clearance of lithium, inducing high risk of lithium toxicity 2
• Requires periodic lithium level monitoring when coadministered 2

Medications Requiring Careful Monitoring

Renin-Angiotensin System Inhibitors

• ACE inhibitors and ARBs with loop diuretics increase risk of hypotension and renal impairment 2
• Not contraindicated but requires close monitoring 1, 4

Radiocontrast Agents

• Loop diuretics increase risk of renal toxicity from radiocontrast 2

Corticosteroids and ACTH

• Increase risk of hypokalemia when combined with loop diuretics 2

CYP2C9 Inhibitors/Inducers

• Inhibitors (amiodarone, fluconazole, miconazole, oxandrolone): Decrease torsemide clearance, increase plasma levels 2
• Inducers (rifampin): Increase clearance, decrease plasma levels 2
• Monitor diuretic effect and blood pressure; adjust dose as necessary 2

Cholestyramine

• Decreases absorption of oral loop diuretics 2
• If coadministration necessary: give loop diuretic at least 1 hour before or 4-6 hours after cholestyramine 2

Organic Anion Drugs

• Probenecid and similar drugs reduce tubular secretion of loop diuretics, decreasing diuretic activity 2

Clinical Pitfalls

Common mistake: Continuing NSAIDs in heart failure patients on loop diuretics. The European Heart Journal guidelines explicitly state to "avoid non-steroidal anti-inflammatory drugs" in this population 1. This is not merely a precaution—NSAIDs directly antagonize the therapeutic effect you're trying to achieve.

Timing matters: For ethacrynic acid specifically, it is contraindicated in infants until further experience accumulates 5. It should be reserved for sulfa-sensitive patients since it's the only loop diuretic without a sulfa moiety 6.

Monitoring imperative: When using combinations that aren't absolutely contraindicated but high-risk (like with ACE inhibitors), check blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment, at 3 months, and subsequently at 6-monthly intervals 1.